My Trading Account β†’
β–Ύ
Trading Profile Active
Active Trader
Verified Trader
⚑ My $100K Trading Account β†’ β˜… My Saved Watchlist β†’
🟒 My $100K Account β†’ Today Screener Big Ideas Track Record πŸ’° $100K Arena 🎲 Predictions πŸ›οΈ Insiders 8 Analysts

National Healthcare Properties Inc. (NHP) Dividend Safety Gauge & 10-Year DRIP Compounder

$15.49 +2.65% NASDAQ β€’ Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $15.53

National Healthcare Properties Inc. (NHP) carries a Roarable Rating of D- (Sell) with 43/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D- β€’ SELL / AVOID Cap $1.10B
πŸ“€ Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚑ INSTANT AI QUANT PREVIEW β€’ $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on NHP Below β€” or Connect Your Own ChatGPT / Claude
πŸ€– Mara Quenwick β€’ AI Quant Lead (Click for Instant Brief) Is NHP stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
β–Ό

As of 2026-11-03, National Healthcare Properties Inc. (NASDAQ: NHP) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 43/100 at a spot price of $15.49 (+2.65% 1D, market cap $1.10B). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 9/20, SEC Balance-Sheet Forensics 10/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 5/20. Across 1097 tracked Financials issuers, NHP ranks #855 in composite RQD confidence.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Ellis Vennor β€’ AI Peer & Flow Quant (Click for Instant Brief) How does NHP compare to DEA and LADR in the Financials sector?
β–Ό

Within the Financials sector (Real Estate Investment Trusts), NHP carries a Roarable D- (43/100 RQD), trailing P/E of N/A, gross margin of β€”, and ROIC of 0.5%. By comparison, DEA (Easterly Government Properties Inc.) holds a D grade (45/100 RQD, P/E 82.4x, ROIC 1.0%, cap $1.07B) and LADR (Ladder Capital Corp (Class A)) posts a D+ grade (53/100 RQD, P/E 18.5x, ROIC 4.3%, cap $1.17B). Among the 5-stock peer group, LADR leads on earnings multiple (18.5x) while CSR leads on capital efficiency (7.2% ROIC).

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Gideon Ashmere β€’ AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for NHP?
β–Ό

Per NHP's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001561032), National Healthcare Properties Inc. generated $342.3M in revenue (-3.3% YoY), $0 in net income, and $7.0M in free cash flow against $1.71B in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Financials with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists β€” not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
πŸ›‘οΈ Portfolio Crash X-Ray
EXT / AFTER-HRS: $15.53 (+0.29%)🧬 Dilution Drag (+1.92% YoY Shares)βš™οΈ Cash Engine: 11/20 (D+) β€’ 2% FCF Margin
Verify 90D Bucket Audit β†’
πŸ“Š Historical Track Record Warning: Scores below 50 (43/100 Β· D-) historically underperformed SPY in 71% of rolling 90-day windows (-6.7% avg 90D alpha vs SPY β€’ 29.0% hit rate).
Audit Bucket Track Record β†’
RQD QUANT TACHOMETERSELL / AVOID β€’ D-
025507510043
2-of-3 Quant Analysts Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) β€” not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR RQD RADARRw D- Β· Rk D
Cash (11)Whales (9)SEC (10)Macro (8)CEO (5)
Each axis scored 0–20
12M PRICE TARGET CONE-6.8% Base Target
$18 Bull$14 Base$11 Bear
πŸ“¬ FREE NHP RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: β€” (No Active Options Snapshot on file for NHP)Realized 20D OHLCV Swing Band: Β±9.7%
Deterministic 5-Pillar Attribution (43/100 Composite)
πŸ” WHY NHP SCORES 43/100 (D-) β€” TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
β–² #1 Bullish Driver: Cash Engine Quality+11/20 pts (26% of score)

SEC XBRL FY 2025 (10-K): 2% FCF Margin ($7.0M FCF) & 52% Gross Margin

β–² #2 Bullish Driver: SEC 10-K Forensic Risk+10/20 pts (23% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) β€’ Piotroski F-Score 2/9

β–Ό #1 Drag / Risk Factor: Insider Conviction & Share Dilution5/20 pts (-15 pt drag)

Dilution Drag (+1.92% YoY Shares) & executive Form 4 sales trim 15 pts from alignment

πŸ“ˆ PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 β†’ Q2 β†’ Q3 β†’ Current
Q1 (-3Q)
35
Grade E$14.67+0.5% Next Q
Q2 (-2Q)
38
Grade E$14.75-0.3% Next Q
Q3 (-1Q)
40
Grade D$14.70+5.4% Next Q
Current
43
Grade D-$15.49-6.7% Hist 90D Ξ±
Trajectory: E (35) β†’ D- (43)Full Audit β†’
βš”οΈ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

βš”οΈ Adversarial Opposing Case: What Could Spark a NHP Turnaround Squeeze

Gideon Ashmere Forensic Desk β†’

While NHP currently carries a cautious 43/100 (D-) rating due to Insider Conviction & Share Dilution (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

πŸš€ Contrarian Squeeze Trigger #1

Established market leader in Financials with deep daily trading liquidity.

πŸš€ Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($15.71) and Max Pain ($16.26) forces dealer call-delta covering toward $18.33.

πŸš€ Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.92% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $NHPβ€’ $2.4M Crowd Pool β€’ Kalshi / Polymarket Composite
Contract: β€œNHP Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
CASH DIVIDEND + BUYBACK YIELD
0.6% Total Yield
0% Cash ($0.00/yr) + 0.6% Buybacks
PAYOUT SAFETY SPEEDOMETER
74/100 β€’ REINVESTING IN GROWTH + BUYBACKS
FREE CASH FLOW PAYOUT RATIO
0% (100% Reinvested)
Retains cash flow for R&D and share repurchases
INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (5.5% EST. ANNUAL)

$10,000 Compounded Over 10 Years β†’ $17,081

Est. Year-10 Shareholder Yield: $102/yr
$10.6K
Yr 1
$11.1K
Yr 2
$11.7K
Yr 3
$12.4K
Yr 4
$13.1K
Yr 5
$13.8K
Yr 6
$14.5K
Yr 7
$15.3K
Yr 8
$16.2K
Yr 9
$17.1K
Yr 10
ON-DEMAND RQD QUANT WORKSHOP β€’ SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring NHP)

  • βœ“Walkthrough of NHP's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • βœ“3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • βœ“Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
NHP // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +18.52%β–Ό DESCENDING CHANNEL
2026-11-04O $15.08H $15.49L $15.08C $15.49VOL 1.05M
RES: $16.01SUP: $14.27SMA50: $15.71SMA200: $15.16
$17.79$16.41$15.03$13.64$12.26RES $16.01SUP $14.27$15.492026-05-052026-06-182026-08-052026-09-212026-11-04
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

NHP Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth

vs. -3.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on NHP today. View full Setup Ledger β†’

πŸ¦‹ Documented & Second-Order Butterfly Connections Open Graph β†’

No direct multi-tier Butterfly edges indexed yet for NHP. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for NHP today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk β†’
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT β€’ SEC EDGAR XBRL Γ— RQD PEER BENCHMARK

πŸ“Š Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (NHP)

1. Head-to-Head Financials Peer Comparison (NHP vs. DEA, LADR, UNIT, CSR)

Industry: Real Estate Investment Trusts (172 Tracked Issuers)

Across 1097 tracked Financials securities in the Roarable RQD universe, National Healthcare Properties Inc. (NHP) ranks #855 by composite RQD confidence (43/100, grade D-) and #533 by equity capitalization ($1.10B). Within this direct 5-issuer industry benchmark cohort, LADR leads on earnings valuation at 18.5x trailing P/E, while CSR leads on capital efficiency and profitability with 7.2% ROIC and β€” gross margin. CSR currently holds the highest overall quantitative score in the immediate peer group at 55/100 (D+) compared with NHP at 43/100 (D-).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
NHP ACTIVE
National Healthcare Properties Inc.
D- 43/100 β€” β€” 0.5% +2.65% $1.10B Benchmark Subject
DEA
Easterly Government Properties Inc.
D 45/100 82.4x β€” 1.0% -0.09% $1.07B /dea-vs-nhp β†’
LADR
Ladder Capital Corp (Class A)
D+ 53/100 18.5x β€” 4.3% -1.83% $1.17B /ladr-vs-nhp β†’
UNIT
Uniti Group Inc.
E 30/100 β€” β€” 2.1% +2.43% $1.20B /unit-vs-nhp β†’
CSR
D/B/A Centerspace
D+ 55/100 57.7x β€” 7.2% -3.23% $993.7M /csr-vs-nhp β†’

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K β€’ FILED 2025-12-31 β€’ CIK 0001561032 β†—

In its most recent audited fiscal period (FY2025, filed 2025-12-31), National Healthcare Properties Inc. (NHP) reported GAAP revenue of $342.3M (-3.3% vs. FY2024 revenue of $353.8M , and -1.1% cumulative change since FY2023) , GAAP net income of $0, operating cash flow of $7.0M, and free cash flow of $7.0M (+108.7% YoY). On the balance sheet, NHP closed FY2025 with $1.71B in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 2/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $342.3M $0 $7.0M $7.0M $1.71B β€”
FY2024 (FY) 2024-12-31 $353.8M $0 -$79.8M -$79.8M $1.95B β€”
FY2023 (FY) 2023-12-31 $345.9M $0 $21.6M $21.6M β€” β€”

3. NHP Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

βœ“ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is NHP stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, National Healthcare Properties Inc. (NASDAQ: NHP) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 43/100 at a spot price of $15.49 (+2.65% 1D, market cap $1.10B). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 9/20, SEC Balance-Sheet Forensics 10/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 5/20. Across 1097 tracked Financials issuers, NHP ranks #855 in composite RQD confidence.

How does NHP compare to DEA and LADR in the Financials sector?

Within the Financials sector (Real Estate Investment Trusts), NHP carries a Roarable D- (43/100 RQD), trailing P/E of N/A, gross margin of β€”, and ROIC of 0.5%. By comparison, DEA (Easterly Government Properties Inc.) holds a D grade (45/100 RQD, P/E 82.4x, ROIC 1.0%, cap $1.07B) and LADR (Ladder Capital Corp (Class A)) posts a D+ grade (53/100 RQD, P/E 18.5x, ROIC 4.3%, cap $1.17B). Among the 5-stock peer group, LADR leads on earnings multiple (18.5x) while CSR leads on capital efficiency (7.2% ROIC).

What are the biggest fundamental strengths and SEC risk factors for NHP?

Per NHP's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001561032), National Healthcare Properties Inc. generated $342.3M in revenue (-3.3% YoY), $0 in net income, and $7.0M in free cash flow against $1.71B in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Financials with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

Where is NHP trading relative to its 50-day, 200-day, and 52-week technical levels?

NHP last traded at $15.49 (+2.65% on volume of 1,199,698 shares), positioning the stock -1.40% below its 50-day simple moving average ($15.71) and +2.18% above its 200-day simple moving average ($15.16). Across its 52-week range of $11.25 to $17.46, NHP sits at the 68.3% percentile with a 14-day RSI of 46.4 (NEUTRAL RANGE) and an implied next-earnings move of Β±9.7% ($13.99 to $16.99).

ROARABLE RATING BRIEF β€’ RQD 43/100 (D-) βœ“ SEC XBRL & RQD VERIFIED

NHP β€” National Healthcare Properties Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

National Healthcare Properties Inc. (NHP) earns a live Roarable RQD composite score of 43/100, corresponding to a D- letter grade (Roarable Sell) at a spot price of $15.49 (+2.65% 1D, market capitalization $1.10B).

  • Fundamental Cash Engine (11/20): Anchored by return on invested capital (ROIC) of 0.5%, gross margin of β€”, operating margin of 1.0%, and free cash flow yield of 0.64%.
  • Whale 13F & Options Flow (9/20) + Insider Conviction (5/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (8/20) + Forensic Balance Sheet (10/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 2/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

National Healthcare Properties Inc. (NHP) is a NASDAQ-listed issuer in the Financials sector, operating within the Real Estate Investment Trusts industry..1B.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), National Healthcare Properties Inc. (NHP) reported $342.3M in annual revenue (up from $353.8M in FY2024, -3.3% YoY) and $0 in GAAP net income. Over the multi-year SEC filing window from FY2023 ($345.9M revenue, $0 net income) through FY2025, NHP scaled operating cash flow to $7.0M and free cash flow to $7.0M, backed by $1.71B in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • πŸ‚ Primary Bull Case (D- β€’ RQD 43/100): Established market leader in Financials with deep daily trading liquidity. Free cash flow yield of 0.64% and institutional whale pillar of 9/20. With Fundamental Cash Engine at 11/20 and Institutional Whale Flow at 9/20, sustained execution supports upside toward the upper end of the $11.25 – $17.46 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against 1.0% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

The sector and industry classification (Financials / Real Estate Investment Trusts) is the only contextual linkage provided. Investors should watch the October 19, 2026 lock-up expiration as the one dated near-term supply event identified in the news wire.

  • Key Question #1: Can NHP sustain or expand its 1.0% operating margin and 0.5% ROIC against Real Estate Investment Trusts peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $342.3M and free cash flow of $7.0M, how will capital allocation balance growth reinvestment against $0 in total debt?
  • Key Question #3: How sensitive is NHP's equity valuation to Financials capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

NHP Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for National Healthcare Properties Inc. (NHP) β€’ Click "Debate This Headline" to argue it in the Roar Pit below

πŸ’¬ Jump to NHP Debate Forum (3) ↓
πŸ”₯ THE ROAR PIT β€’ LIVE COMMUNITY DEBATE 3 Active Posts & Replies

NHP Bull vs. Bear Conversation Board β€” What's Your Call at $15.49?

πŸ‚ 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON NHP 🐻 33% BEARISH CONVICTION
1. Pick Your Side on NHP:
πŸ’‘ Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
MI MidwestValue RQD DEBATE OPENER β€’ Fundamental Long-Only πŸ‚ BULLISH 🎯 Target: $18.85 (+25.0%)
πŸ“Œ Pinned Debate

Operating income turned positive to $3.3M in FY 2025 after a -$123.5M loss in FY 2024, and the stock trades near $14.96 within a $11.25

Don't sleep on NHP's setup in Financials. Operating income turned positive to $3.3M in FY 2025 after a -$123.5M loss in FY 2024, and the stock trades near $14.96 within a $11.25 - $17.46 52-week range.. Beta of 1.0 means it moves fast when momentum turns, and the 5-pillar RQD gauge (43/100) backs up the fundamental quality.

EarningsSniper πŸ‚ BULL

Both sides have a point here β€” NHP's 10/20 balance sheet score keeps downside contained, so the real swing factor next earnings call is backlog and FCF conversion.

FA FadeTheHype RQD DEBATE OPENER β€’ Contrarian Tape Reader 🐻 BEARISH 🎯 Target: $11.76 (-22.0%)
Spot @ $15.08

The RQD rating of 41 (D-) is weighed down by a Piotroski F-Score of 2/9, ROIC of 0.5%, and an FCF yield of 0.64%, with no dividend and

Here is the bear case nobody on the bull side wants to address on NHP: The RQD rating of 41 (D-) is weighed down by a Piotroski F-Score of 2/9, ROIC of 0.5%, and an FCF yield of 0.64%, with no dividend and weak insider and institutional flow.. At current EV/EBITDA multiples, even a small guidance miss in Real Estate Investment Trusts triggers a 12-15% air pocket.

LIVE TAPE